Bayesian inference of the sites of perturbations in metabolic pathways via Markov chain Monte Carlo
Open Access
- 20 March 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 24 (9) , 1191-1197
Abstract
Motivation: Genetic modifications or pharmaceutical interventions can influence multiple sites in metabolic pathways, and often these are ‘distant’ from the primary effect. In this regard, the ability to identify target and off-target effects of a specific compound or gene therapy is both a major challenge and critical in drug discovery. Results: We applied Markov Chain Monte Carlo (MCMC) for parameter estimation and perturbation identification in the kinetic modeling of metabolic pathways. Variability in the steady-state measurements in cells taken from a population can be caused by differences in initial conditions within the population, by variation of parameters among individuals and by possible measurement noise. MCMC-based parameter estimation is proposed as a method to help in inferring parameter distributions, taking into account uncertainties in the initial conditions and in the measurement data. The inferred parameter distributions are then used to predict changes in the network via a simple classification method. The proposed technique is applied to analyze changes in the pathways of pyruvate metabolism of mutants of Lactococcus lactis, based on previously published experimental data. Availability: MATLAB code used in the simulations is available from ftp://anonymous@dbkweb.mib.man.ac.uk/pub/Bioinformatics_BJ.zip Contact:bayujw@ieee.org Supplementary information: Supplementary data are available at Bioinformatics online.Keywords
This publication has 29 references indexed in Scilit:
- Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?Nature Reviews Drug Discovery, 2008
- Information-theoretic sensitivity analysis: a general method for credit assignment in complex networksJournal of The Royal Society Interface, 2007
- Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in YeastCell, 2006
- Probe-level measurement error improves accuracy in detecting differential gene expressionBioinformatics, 2006
- Bayesian parameter estimation with informative priors for nonlinear systemsAIChE Journal, 2005
- Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancerFundamental & Clinical Pharmacology, 2004
- Protein engineering of pyruvate carboxylaseEuropean Journal of Biochemistry, 2004
- Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathwaysNature Biotechnology, 2003
- Drug target validation and identification of secondary drug target effects using DNA microarraysNature Medicine, 1998
- Metabolic control analysis of moiety‐conserved cyclesEuropean Journal of Biochemistry, 1986